Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 09, 2024 Filed May 10, 2024 19:52 UTC |
Henkel Robert JDirector
|
GrantCommon Stock | 11,154 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-009852 · form4.xml · nonDerivative · entry 1 Henkel Robert J · CIK 0001789650 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,498 F1 · security: Restricted stock grant which vests the earlier of (i) one year from the grant date and (ii) the date of the next annual meeting that is at least 50 weeks following the grant date. Read SEC document |
| May 01, 2024 Filed May 3, 2024 20:03 UTC |
Bernocchi Perry AEVP, CEO,. Patient Direct
|
SaleCommon Stock | 20,204 | $24.27 | $490,258.14 |
DisclosureSEC source: 0001062993-24-009327 · form4.xml · nonDerivative · entry 2 Bernocchi Perry A · CIK 0001967402 · EVP, CEO,. Patient Direct 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 170,497 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective August 11, 2023. F2 · price: Weighted average of the sale price range of $23.870 - $24.800 Read SEC document |
| May 01, 2024 Filed May 3, 2024 20:03 UTC |
Bernocchi Perry AEVP, CEO,. Patient Direct
|
SaleCommon Stock | 3,890 | $24.53 | $95,421.70 |
DisclosureSEC source: 0001062993-24-009327 · form4.xml · nonDerivative · entry 1 Bernocchi Perry A · CIK 0001967402 · EVP, CEO,. Patient Direct 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 190,701 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective August 11, 2023. Read SEC document |
| April 22, 2024 Filed Apr 23, 2024 22:00 UTC |
Leon Jonathan ASVP, Corporate Treasurer
|
SaleCommon Stock | 5,000 | $24.84 | $124,200.00 |
DisclosureSEC source: 0001062993-24-008731 · form4.xml · nonDerivative · entry 1 Leon Jonathan A · CIK 0001740352 · SVP, Corporate Treasurer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 84,673 F1 · shares: The disposition of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective August 9, 2023. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 01:39 UTC |
Bernocchi Perry AEVP, CEO,. Patient Direct
|
Tax withholdingCommon Stock | 14,946 | $24.99 | $373,500.54 |
DisclosureSEC source: 0001062993-24-006699 · form4.xml · nonDerivative · entry 1 Bernocchi Perry A · CIK 0001967402 · EVP, CEO,. Patient Direct 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 194,591 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 01:38 UTC |
Leon Jonathan ASVP, Corporate Treasurer
|
Tax withholdingCommon Stock | 3,086 | $24.99 | $77,119.14 |
DisclosureSEC source: 0001062993-24-006698 · form4.xml · nonDerivative · entry 1 Leon Jonathan A · CIK 0001740352 · SVP, Corporate Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,673 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 01:38 UTC |
Long Andrew GEVP, CEO P&HS
|
Tax withholdingCommon Stock | 22,785 | $24.99 | $569,397.15 |
DisclosureSEC source: 0001062993-24-006697 · form4.xml · nonDerivative · entry 1 Long Andrew G · CIK 0001714880 · EVP, CEO P&HS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 249,780 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 01:37 UTC |
Lowry Michael WayneSVP, Corporate Controller
|
Tax withholdingCommon Stock | 3,086 | $24.99 | $77,119.14 |
DisclosureSEC source: 0001062993-24-006696 · form4.xml · nonDerivative · entry 1 Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,222 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 01:37 UTC |
Pesicka Edward ADirector · President & CEO
|
Tax withholdingCommon Stock | 58,126 | $24.99 | $1,452,568.74 |
DisclosureSEC source: 0001062993-24-006695 · form4.xml · nonDerivative · entry 1 Pesicka Edward A · CIK 0001439487 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 799,670 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:53 UTC |
Starck Daniel JEVP, Business Excellence
|
GrantCommon Stock | 32,975 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-005544 · form4.xml · nonDerivative · entry 1 Starck Daniel J · CIK 0001345856 · EVP, Business Excellence 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,058 F1 · security: Restricted stock grant which vests one-third per year over three years. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:53 UTC |
Sarkar SnehashishChief Information Officer
|
GrantCommon Stock | 14,205 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-005542 · form4.xml · nonDerivative · entry 1 Sarkar Snehashish · CIK 0001951379 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,439 F1 · security: Restricted stock grant which vests one-third per year over three years. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:53 UTC |
Pesicka Edward ADirector · President & CEO
|
GrantCommon Stock | 148,134 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-005540 · form4.xml · nonDerivative · entry 1 Pesicka Edward A · CIK 0001439487 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 857,796 F1 · security: Restricted stock grant which vests one-third per year over three years. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:52 UTC |
Leon Jonathan ASVP, Corporate Treasurer
|
GrantCommon Stock | 17,046 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-005539 · form4.xml · nonDerivative · entry 1 Leon Jonathan A · CIK 0001740352 · SVP, Corporate Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,759 F1 · security: Restricted stock grant which vests one-third per year over three years. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:52 UTC |
Galloway Heath HEVP,General Counsel & CorpSecy
|
GrantCommon Stock | 24,351 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-005536 · form4.xml · nonDerivative · entry 1 Galloway Heath H · CIK 0001976274 · EVP,General Counsel & CorpSecy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,681 F1 · security: Restricted stock grant which vests one-third per year over three years. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:50 UTC |
Long Andrew GEVP, CEO P&HS
|
GrantCommon Stock | 50,731 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-005532 · form4.xml · nonDerivative · entry 1 Long Andrew G · CIK 0001714880 · EVP, CEO P&HS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 272,565 F1 · security: Restricted stock grant which vests one-third per year over three years. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:48 UTC |
Bernocchi Perry AEVP, CEO,. Patient Direct
|
GrantCommon Stock | 44,643 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-005529 · form4.xml · nonDerivative · entry 1 Bernocchi Perry A · CIK 0001967402 · EVP, CEO,. Patient Direct 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 209,537 F1 · security: Restricted stock grant which vests one-third per year over three years. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:49 UTC |
Lowry Michael WayneSVP, Corporate Controller
|
GrantCommon Stock | 10,654 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-005531 · form4.xml · nonDerivative · entry 1 Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,308 F1 · security: Restricted stock grant which vests one-third per year over three years. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:48 UTC |
Bruni Alexander JEVP, CFO
|
GrantCommon Stock | 24,351 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-005528 · form4.xml · nonDerivative · entry 1 Bruni Alexander J · CIK 0001949360 · EVP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,808 F1 · security: Restricted stock grant which vests one-third per year over three years. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 01:00 UTC |
Lowry Michael WayneSVP, Corporate Controller
|
SaleCommon Stock | 10,000 | $25.00 | $250,000.00 |
DisclosureSEC source: 0001062993-24-004866 · form4.xml · nonDerivative · entry 1 Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 71,654 F1 · kind: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 7, 2023. Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 21:15 UTC |
Leon Jonathan ASVP, Corporate Treasurer
|
SaleCommon Stock | 5,000 | $22.00 | $110,000.00 |
DisclosureSEC source: 0001062993-24-004073 · form4.xml · nonDerivative · entry 1 Leon Jonathan A · CIK 0001740352 · SVP, Corporate Treasurer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 75,713 F1 · shares: The disposition of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective August 9, 2023. Read SEC document |
| February 07, 2024 Filed Feb 8, 2024 21:01 UTC |
Galloway Heath HEVP,General Counsel & CorpSecy
|
Tax withholdingCommon Stock | 107 | $19.96 | $2,135.72 |
DisclosureSEC source: 0001062993-24-002541 · form4.xml · nonDerivative · entry 2 Galloway Heath H · CIK 0001976274 · EVP,General Counsel & CorpSecy 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,330 F2 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| February 07, 2024 Filed Feb 8, 2024 21:01 UTC |
Galloway Heath HEVP,General Counsel & CorpSecy
|
SaleCommon Stock | 97 | $19.91 | $1,931.27 |
DisclosureSEC source: 0001062993-24-002541 · form4.xml · nonDerivative · entry 1 Galloway Heath H · CIK 0001976274 · EVP,General Counsel & CorpSecy 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,437 F1 · kind: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective August 10, 2023. Read SEC document |
| January 17, 2024 Filed Jan 18, 2024 13:52 UTC |
Leon Jonathan ASVP, Corporate Treasurer
|
GiftCommon Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-000996 · form4.xml · nonDerivative · entry 2 Leon Jonathan A · CIK 0001740352 · SVP, Corporate Treasurer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 80,713 F1 · shares: The disposition of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective August 9, 2023. Read SEC document |
| January 17, 2024 Filed Jan 18, 2024 13:52 UTC |
Leon Jonathan ASVP, Corporate Treasurer
|
SaleCommon Stock | 7,500 | $18.08 | $135,600.00 |
DisclosureSEC source: 0001062993-24-000996 · form4.xml · nonDerivative · entry 1 Leon Jonathan A · CIK 0001740352 · SVP, Corporate Treasurer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 83,213 F1 · shares: The disposition of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective August 9, 2023. Read SEC document |
| December 29, 2023 Filed Jan 18, 2024 13:52 UTC |
Bernocchi Perry AEVP, CEO,. Patient Direct
|
GrantCommon Stock | 547 | $16.18 | $8,852.65 |
DisclosureSEC source: 0001062993-24-000995 · form4.xml · nonDerivative · entry 1 Bernocchi Perry A · CIK 0001967402 · EVP, CEO,. Patient Direct 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 164,894 F1 · kind: Shares acquired under the Owens & Minor Teammate Stock Purchase Plan in a transaction that was exempt under Rule 16b-3(c). Read SEC document |
| December 29, 2023 Filed Jan 18, 2024 13:51 UTC |
Galloway Heath HEVP,General Counsel & CorpSecy
|
GrantCommon Stock | 55 | $16.18 | $890.12 |
DisclosureSEC source: 0001062993-24-000994 · form4.xml · nonDerivative · entry 1 Galloway Heath H · CIK 0001976274 · EVP,General Counsel & CorpSecy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,534 F1 · kind: Shares acquired under the Owens & Minor Teammate Stock Purchase Plan in a transaction that was exempt under Rule 16b-3(c). Read SEC document |
| December 29, 2023 Filed Jan 18, 2024 13:51 UTC |
Lowry Michael WayneSVP, Corporate Controller
|
GrantCommon Stock | 555 | $16.18 | $8,982.12 |
DisclosureSEC source: 0001062993-24-000993 · form4.xml · nonDerivative · entry 1 Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,654 F1 · kind: Shares acquired under the Owens & Minor Teammate Stock Purchase Plan in a transaction that was exempt under Rule 16b-3(c). Read SEC document |
| December 29, 2023 Filed Jan 18, 2024 13:45 UTC |
Sarkar SnehashishChief Information Officer
|
GrantCommon Stock | 555 | $16.18 | $8,982.12 |
DisclosureSEC source: 0001062993-24-000988 · form4.xml · nonDerivative · entry 1 Sarkar Snehashish · CIK 0001951379 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,234 F1 · kind: Shares acquired under the Owens & Minor Teammate Stock Purchase Plan in a transaction that was exempt under Rule 16b-3(c). Read SEC document |
| December 29, 2023 Filed Jan 18, 2024 13:45 UTC |
Pesicka Edward ADirector · President & CEO
|
GrantCommon Stock | 366 | $16.18 | $5,923.34 |
DisclosureSEC source: 0001062993-24-000987 · form4.xml · nonDerivative · entry 1 Pesicka Edward A · CIK 0001439487 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 709,662 F1 · kind: Shares acquired under the Owens & Minor Teammate Stock Purchase Plan in a transaction that was exempt under Rule 16b-3(c). Read SEC document |
| December 20, 2023 Filed Dec 22, 2023 02:41 UTC |
Leon Jonathan ASVP, Corporate Treasurer
|
GiftCommon Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-023061 · form4.xml · nonDerivative · entry 2 Leon Jonathan A · CIK 0001740352 · SVP, Corporate Treasurer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 90,713 F1 · shares: The disposition of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective August 9, 2023. Read SEC document |
| December 20, 2023 Filed Dec 22, 2023 02:41 UTC |
Leon Jonathan ASVP, Corporate Treasurer
|
SaleCommon Stock | 5,000 | $21.34 | $106,700.00 |
DisclosureSEC source: 0001062993-23-023061 · form4.xml · nonDerivative · entry 1 Leon Jonathan A · CIK 0001740352 · SVP, Corporate Treasurer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 93,213 F1 · shares: The disposition of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective August 9, 2023. Read SEC document |
| November 22, 2023 Filed Nov 23, 2023 02:50 UTC |
Bernocchi Perry AEVP, CEO,. Patient Direct
|
SaleCommon Stock | 19,302 | $18.75 | $361,916.36 |
DisclosureSEC source: 0001062993-23-021402 · form4.xml · nonDerivative · entry 1 Bernocchi Perry A · CIK 0001967402 · EVP, CEO,. Patient Direct 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 164,347 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective August 11, 2023. F2 · price: Weighted average of the sale price range of $18.61 - $19.38. Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 13:18 UTC |
Leon Jonathan ASVP, Corporate Treasurer
|
SaleCommon Stock | 5,000 | $18.62 | $93,100.00 |
DisclosureSEC source: 0001062993-23-021236 · form4.xml · nonDerivative · entry 1 Leon Jonathan A · CIK 0001740352 · SVP, Corporate Treasurer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 98,213 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective August 9, 2023. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 14:00 UTC |
Sarkar SnehashishChief Information Officer
|
Tax withholdingCommon Stock | 1,159 | $18.07 | $20,943.13 |
DisclosureSEC source: 0001062993-23-021038 · form4.xml · nonDerivative · entry 1 Sarkar Snehashish · CIK 0001951379 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,679 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| November 10, 2023 Filed Nov 14, 2023 00:02 UTC |
Bruni Alexander JEVP, CFO
|
SaleCommon Stock | 12,668 | $17.57 | $222,576.76 |
DisclosureSEC source: 0001062993-23-020715 · form4.xml · nonDerivative · entry 1 Bruni Alexander J · CIK 0001949360 · EVP, CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 41,457 F1 · kind: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective August 8, 2023. Read SEC document |
| November 10, 2023 Filed Nov 14, 2023 00:02 UTC |
Galloway Heath HEVP,General Counsel & CorpSecy
|
SaleCommon Stock | 5,500 | $17.57 | $96,635.00 |
DisclosureSEC source: 0001062993-23-020716 · form4.xml · nonDerivative · entry 1 Galloway Heath H · CIK 0001976274 · EVP,General Counsel & CorpSecy 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,479 F1 · kind: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective August 10, 2023. Read SEC document |
| October 27, 2023 Filed Oct 30, 2023 13:02 UTC |
Leon Jonathan ASVP, Corporate Treasurer
|
Tax withholdingCommon Stock | 390 | $14.10 | $5,499.00 |
DisclosureSEC source: 0001062993-23-019800 · form4.xml · nonDerivative · entry 1 Leon Jonathan A · CIK 0001740352 · SVP, Corporate Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,213 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| August 15, 2023 Filed Aug 16, 2023 20:02 UTC |
Gomez Tammy LEVP, CHRO
|
Tax withholdingCommon Stock | 1,506 | $19.63 | $29,562.78 |
DisclosureSEC source: 0001062993-23-016599 · form4.xml · nonDerivative · entry 1 Gomez Tammy L · CIK 0001937481 · EVP, CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,782 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| August 15, 2023 Filed Aug 16, 2023 20:02 UTC |
Bruni Alexander JEVP, CFO
|
Tax withholdingCommon Stock | 328 | $19.63 | $6,438.64 |
DisclosureSEC source: 0001062993-23-016598 · form4.xml · nonDerivative · entry 1 Bruni Alexander J · CIK 0001949360 · EVP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,125 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| July 27, 2023 Filed Jul 31, 2023 20:03 UTC |
Sarkar SnehashishChief Information Officer
|
GrantCommon Stock | 13,624 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-015479 · form4.xml · nonDerivative · entry 1 Sarkar Snehashish · CIK 0001951379 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,838 F1 · security: Restricted stock grant with 3-year cliff vesting. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 22:41 UTC |
Lowry Michael WayneSVP, Corporate Controller
|
GrantCommon Stock | 739 | $16.24 | $11,997.67 |
DisclosureSEC source: 0001062993-23-014520 · form4.xml · nonDerivative · entry 1 Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,099 F1 · kind: Shares acquired under the Owens & Minor Teammate Stock Purchase Plan in a transaction that was exempt under Rule 16b-3(c). Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 22:40 UTC |
Pesicka Edward ADirector · President & CEO
|
GrantCommon Stock | 923 | $16.24 | $14,984.91 |
DisclosureSEC source: 0001062993-23-014519 · form4.xml · nonDerivative · entry 1 Pesicka Edward A · CIK 0001439487 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 709,296 F1 · kind: Shares acquired under the Owens & Minor Teammate Stock Purchase Plan in a transaction that was exempt under Rule 16b-3(c). Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 22:40 UTC |
Bernocchi Perry AEVP, CEO,. Patient Direct
|
GrantCommon Stock | 554 | $16.24 | $8,994.19 |
DisclosureSEC source: 0001062993-23-014518 · form4.xml · nonDerivative · entry 1 Bernocchi Perry A · CIK 0001967402 · EVP, CEO,. Patient Direct 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 183,649 F1 · kind: Shares acquired under the Owens & Minor Teammate Stock Purchase Plan in a transaction that was exempt under Rule 16b-3(c). Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 22:39 UTC |
Galloway Heath HEVP,General Counsel & CorpSecy
|
GrantCommon Stock | 56 | $16.24 | $909.16 |
DisclosureSEC source: 0001062993-23-014517 · form4.xml · nonDerivative · entry 1 Galloway Heath H · CIK 0001976274 · EVP,General Counsel & CorpSecy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,979 F1 · kind: Shares acquired under the Owens & Minor Teammate Stock Purchase Plan in a transaction that was exempt under Rule 16b-3(c). Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 22:39 UTC |
Sarkar SnehashishChief Information Officer
|
GrantCommon Stock | 739 | $16.24 | $11,997.67 |
DisclosureSEC source: 0001062993-23-014516 · form4.xml · nonDerivative · entry 1 Sarkar Snehashish · CIK 0001951379 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,214 F1 · kind: Shares acquired under the Owens & Minor Teammate Stock Purchase Plan in a transaction that was exempt under Rule 16b-3(c). Read SEC document |
| June 16, 2023 Filed Jun 20, 2023 12:55 UTC |
Pesicka Edward ADirector · President & CEO
|
SaleCommon Stock | 5,455 | $19.28 | $105,161.49 |
DisclosureSEC source: 0001062993-23-013783 · form4.xml · nonDerivative · entry 6 Pesicka Edward A · CIK 0001439487 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 708,373 F1 · kind: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 7, 2023. F7 · price: Weighted average of the sale price range of $19.09 through $19.585 Read SEC document |
| June 16, 2023 Filed Jun 20, 2023 12:55 UTC |
Pesicka Edward ADirector · President & CEO
|
SaleCommon Stock | 27,488 | $19.27 | $529,798.21 |
DisclosureSEC source: 0001062993-23-013783 · form4.xml · nonDerivative · entry 5 Pesicka Edward A · CIK 0001439487 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 713,828 F1 · kind: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 7, 2023. F6 · price: Weighted average of the sale price range of $19.045 through $19.590 Read SEC document |
| June 16, 2023 Filed Jun 20, 2023 12:55 UTC |
Pesicka Edward ADirector · President & CEO
|
SaleCommon Stock | 5,837 | $19.28 | $112,526.85 |
DisclosureSEC source: 0001062993-23-013783 · form4.xml · nonDerivative · entry 4 Pesicka Edward A · CIK 0001439487 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 741,316 F1 · kind: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 7, 2023. F5 · price: Weighted average of the sale price range of $19.085 through $19.585 Read SEC document |
| June 15, 2023 Filed Jun 20, 2023 12:55 UTC |
Pesicka Edward ADirector · President & CEO
|
SaleCommon Stock | 5,455 | $19.23 | $104,902.92 |
DisclosureSEC source: 0001062993-23-013783 · form4.xml · nonDerivative · entry 3 Pesicka Edward A · CIK 0001439487 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 747,153 F1 · kind: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 7, 2023. F4 · price: Weighted average of the sale price range of $18.72 through $19.405 Read SEC document |
| June 15, 2023 Filed Jun 20, 2023 12:55 UTC |
Pesicka Edward ADirector · President & CEO
|
SaleCommon Stock | 5,837 | $19.24 | $112,280.53 |
DisclosureSEC source: 0001062993-23-013783 · form4.xml · nonDerivative · entry 2 Pesicka Edward A · CIK 0001439487 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 752,608 F1 · kind: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 7, 2023. F3 · price: Weighted average of the sale price range of $18.73 through $19.40 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.